HESTERBIO Q4 FY26 Guidance vs Delivery (HESTERBIO Management Mirror)

Did HESTERBIO's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

Hester Biosciences Ltd (HESTERBIO) Q4FY26 Management Mirror - Mar-2026 Qtr

Strategic Revenue Diversification

Management targets a long-term 50:50 revenue mix between Poultry and Animal Healthcare to avoid single-segment dependence, maintaining the Dec'25 Qtr priority of shifting away from tender-driven government business toward direct commercial and export sales. [Status: Reaffirmed]

4 more themes on the ELITE plan.